{"name": "ProNoxis",
 "permalink": "pronoxis",
 "crunchbase_url": "http://www.crunchbase.com/company/pronoxis",
 "homepage_url": "http://www.pronoxis.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "ProNoxis AB",
 "email_address": "",
 "phone_number": "46-709-164608",
 "description": "treatments for autoimmune disorders",
 "created_at": "Tue Jul 07 19:48:33 UTC 2009",
 "updated_at": "Mon Oct 26 11:52:37 UTC 2009",
 "overview": "\u003Cp\u003EProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease (IBD). ProNoxis is a spin-out from Redoxis.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       35],
      "assets/images/resized/0006/3751/63751v1-max-150x150.jpg"],
     [[240,
       57],
      "assets/images/resized/0006/3751/63751v1-max-250x250.jpg"],
     [[240,
       57],
      "assets/images/resized/0006/3751/63751v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "Capital Report Index",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2009,
    "funded_month": 6,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Lund University Bioscience",
         "permalink": "lund-university-bioscience",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0006/1571/61571v1-max-150x150.png"],
             [[156,
               45],
              "assets/images/resized/0006/1571/61571v1-max-250x250.png"],
             [[156,
               45],
              "assets/images/resized/0006/1571/61571v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Karolinska",
         "permalink": "karolinska",
         "image":
          {"available_sizes":
            [[[150,
               48],
              "assets/images/resized/0004/5503/45503v1-max-150x150.png"],
             [[250,
               80],
              "assets/images/resized/0004/5503/45503v1-max-250x250.png"],
             [[250,
               80],
              "assets/images/resized/0004/5503/45503v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Biotech Building - Plan 7 ",
    "address2": "Arvid Wallgrens Backe 20",
    "zip_code": "SE-413 46",
    "city": "G\u00c3\u00b6teborg",
    "state_code": null,
    "country_code": "SWE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        108],
       "assets/images/resized/0006/3752/63752v1-max-150x150.jpg"],
      [[250,
        181],
       "assets/images/resized/0006/3752/63752v1-max-250x250.jpg"],
      [[450,
        326],
       "assets/images/resized/0006/3752/63752v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}